237 related articles for article (PubMed ID: 23142757)
1. Validation of the proteasome as a therapeutic target in Plasmodium using an epoxyketone inhibitor with parasite-specific toxicity.
Li H; Ponder EL; Verdoes M; Asbjornsdottir KH; Deu E; Edgington LE; Lee JT; Kirk CJ; Demo SD; Williamson KC; Bogyo M
Chem Biol; 2012 Dec; 19(12):1535-45. PubMed ID: 23142757
[TBL] [Abstract][Full Text] [Related]
2. Structure- and function-based design of Plasmodium-selective proteasome inhibitors.
Li H; O'Donoghue AJ; van der Linden WA; Xie SC; Yoo E; Foe IT; Tilley L; Craik CS; da Fonseca PC; Bogyo M
Nature; 2016 Feb; 530(7589):233-6. PubMed ID: 26863983
[TBL] [Abstract][Full Text] [Related]
3. Identification of potent and selective non-covalent inhibitors of the Plasmodium falciparum proteasome.
Li H; Tsu C; Blackburn C; Li G; Hales P; Dick L; Bogyo M
J Am Chem Soc; 2014 Oct; 136(39):13562-5. PubMed ID: 25226494
[TBL] [Abstract][Full Text] [Related]
4. Ubiquitin Proteasome System as a Potential Drug Target for Malaria.
Pereira PHS; Curra C; Garcia CRS
Curr Top Med Chem; 2018; 18(5):315-320. PubMed ID: 29701143
[TBL] [Abstract][Full Text] [Related]
5. Mitigating the risk of antimalarial resistance via covalent dual-subunit inhibition of the Plasmodium proteasome.
Deni I; Stokes BH; Ward KE; Fairhurst KJ; Pasaje CFA; Yeo T; Akbar S; Park H; Muir R; Bick DS; Zhan W; Zhang H; Liu YJ; Ng CL; Kirkman LA; Almaliti J; Gould AE; Duffey M; O'Donoghue AJ; Uhlemann AC; Niles JC; da Fonseca PCA; Gerwick WH; Lin G; Bogyo M; Fidock DA
Cell Chem Biol; 2023 May; 30(5):470-485.e6. PubMed ID: 36963402
[TBL] [Abstract][Full Text] [Related]
6. Metabolite extract of Streptomyces hygroscopicus Hygroscopicus inhibit the growth of Plasmodium berghei through inhibition of ubiquitin - proteasome system.
Rivo YB; Alkarimah A; Ramadhani NN; Cahyono AW; Laksmi DA; Winarsih S; Fitri LE
Trop Biomed; 2013 Jun; 30(2):291-300. PubMed ID: 23959495
[TBL] [Abstract][Full Text] [Related]
7. Antimalarials: Novel proteasome inhibitor combats malaria.
Crunkhorn S
Nat Rev Drug Discov; 2016 Apr; 15(4):232-3. PubMed ID: 27032831
[No Abstract] [Full Text] [Related]
8. The proteasome as a target to combat malaria: hits and misses.
Krishnan KM; Williamson KC
Transl Res; 2018 Aug; 198():40-47. PubMed ID: 30009761
[TBL] [Abstract][Full Text] [Related]
9. Development of Potent and Highly Selective Epoxyketone-Based Plasmodium Proteasome Inhibitors.
Almaliti J; Fajtová P; Calla J; LaMonte GM; Feng M; Rocamora F; Ottilie S; Glukhov E; Boura E; Suhandynata RT; Momper JD; Gilson MK; Winzeler EA; Gerwick WH; O'Donoghue AJ
Chemistry; 2023 Apr; 29(20):e202203958. PubMed ID: 36617500
[TBL] [Abstract][Full Text] [Related]
10. Covalent Plasmodium falciparum-selective proteasome inhibitors exhibit a low propensity for generating resistance in vitro and synergize with multiple antimalarial agents.
Stokes BH; Yoo E; Murithi JM; Luth MR; Afanasyev P; da Fonseca PCA; Winzeler EA; Ng CL; Bogyo M; Fidock DA
PLoS Pathog; 2019 Jun; 15(6):e1007722. PubMed ID: 31170268
[TBL] [Abstract][Full Text] [Related]
11. Broad-spectrum antimalarial activity of peptido sulfonyl fluorides, a new class of proteasome inhibitors.
Tschan S; Brouwer AJ; Werkhoven PR; Jonker AM; Wagner L; Knittel S; Aminake MN; Pradel G; Joanny F; Liskamp RM; Mordmüller B
Antimicrob Agents Chemother; 2013 Aug; 57(8):3576-84. PubMed ID: 23689711
[TBL] [Abstract][Full Text] [Related]
12. Antimalarial efficacy of Pongamia pinnata (L) Pierre against Plasmodium falciparum (3D7 strain) and Plasmodium berghei (ANKA).
Satish PVV; Sunita K
BMC Complement Altern Med; 2017 Sep; 17(1):458. PubMed ID: 28893216
[TBL] [Abstract][Full Text] [Related]
13. Development of a Highly Selective Plasmodium falciparum Proteasome Inhibitor with Anti-malaria Activity in Humanized Mice.
Zhan W; Zhang H; Ginn J; Leung A; Liu YJ; Michino M; Toita A; Okamoto R; Wong TT; Imaeda T; Hara R; Yukawa T; Chelebieva S; Tumwebaze PK; Lafuente-Monasterio MJ; Martinez-Martinez MS; Vendome J; Beuming T; Sato K; Aso K; Rosenthal PJ; Cooper RA; Meinke PT; Nathan CF; Kirkman LA; Lin G
Angew Chem Int Ed Engl; 2021 Apr; 60(17):9279-9283. PubMed ID: 33433953
[TBL] [Abstract][Full Text] [Related]
14. Structure-Activity Relationship Studies of Antimalarial
Zhang H; Ginn J; Zhan W; Leung A; Liu YJ; Toita A; Okamoto R; Wong TT; Imaeda T; Hara R; Michino M; Yukawa T; Chelebieva S; Tumwebaze PK; Vendome J; Beuming T; Sato K; Aso K; Rosenthal PJ; Cooper RA; Liverton N; Foley M; Meinke PT; Nathan CF; Kirkman LA; Lin G
J Med Chem; 2023 Jan; 66(2):1484-1508. PubMed ID: 36630286
[TBL] [Abstract][Full Text] [Related]
15. Development of a Potent Inhibitor of the Plasmodium Proteasome with Reduced Mammalian Toxicity.
LaMonte GM; Almaliti J; Bibo-Verdugo B; Keller L; Zou BY; Yang J; Antonova-Koch Y; Orjuela-Sanchez P; Boyle CA; Vigil E; Wang L; Goldgof GM; Gerwick L; O'Donoghue AJ; Winzeler EA; Gerwick WH; Ottilie S
J Med Chem; 2017 Aug; 60(15):6721-6732. PubMed ID: 28696697
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the antimalarial activity of new compounds against Plasmodium falciparum in vitro, and Plasmodium berghei in vivo.
Tedlaouti F; Gasquet M; Delmas F; Timon-David P; Madadi NE; Vanelle P; Maldonado J
J Pharm Belg; 1990; 45(5):306-10. PubMed ID: 2086754
[TBL] [Abstract][Full Text] [Related]
17. Novel inhibitor of Plasmodium histone deacetylase that cures P. berghei-infected mice.
Agbor-Enoh S; Seudieu C; Davidson E; Dritschilo A; Jung M
Antimicrob Agents Chemother; 2009 May; 53(5):1727-34. PubMed ID: 19223622
[TBL] [Abstract][Full Text] [Related]
18. The cryo-EM structure of the Plasmodium falciparum 20S proteasome and its use in the fight against malaria.
Li H; Bogyo M; da Fonseca PC
FEBS J; 2016 Dec; 283(23):4238-4243. PubMed ID: 27286897
[TBL] [Abstract][Full Text] [Related]
19. Validation of Babesia proteasome as a drug target.
Jalovecka M; Hartmann D; Miyamoto Y; Eckmann L; Hajdusek O; O'Donoghue AJ; Sojka D
Int J Parasitol Drugs Drug Resist; 2018 Dec; 8(3):394-402. PubMed ID: 30103207
[TBL] [Abstract][Full Text] [Related]
20. Macrolides rapidly inhibit red blood cell invasion by the human malaria parasite, Plasmodium falciparum.
Wilson DW; Goodman CD; Sleebs BE; Weiss GE; de Jong NW; Angrisano F; Langer C; Baum J; Crabb BS; Gilson PR; McFadden GI; Beeson JG
BMC Biol; 2015 Jul; 13():52. PubMed ID: 26187647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
